We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+37.47%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$323M
AUM Growth
+$43.4M
(+15%)
Cap. Flow
-$16.4M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
39.14%
Holding
98
New
27
Increased
16
Reduced
27
Closed
21
Top Buys
| 1 |
SOLY
Soliton, Inc.
SOLY
|
+$10.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$9.42M |
| 3 |
SPDR Gold Trust
GLD
|
+$9.03M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$7.85M |
| 5 |
Cencora
COR
|
+$7.79M |
Top Sells
| 1 |
Amgen
AMGN
|
+$21.5M |
| 2 |
Envista
NVST
|
+$12.8M |
| 3 |
Boston Scientific
BSX
|
+$10.2M |
| 4 |
AGN
Allergan plc
AGN
|
+$9.74M |
| 5 |
Biogen
BIIB
|
+$8.46M |
Sector Composition
| 1 | Healthcare | 80.54% |
| 2 | Industrials | 2.63% |
| 3 | Financials | 0.97% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coherus Oncology
CHRS
$224M
| $20.3M | 6.27% |
1,135,863
+58,024
| +5% | +$982K |
|
|
2
SPDR Gold Trust
GLD
$131B
| $20.2M | 6.25% |
120,702
+56,000
| +87% | +$9.03M |
|
3
McKesson
MCK
$94.1B
| $14.9M | 4.61% |
97,285
-35,055
| -26% | -$5.06M |
|
4
Teva Pharmaceuticals
TEVA
$37.1B
| $11.9M | 3.67% |
962,796
+390,115
| +68% | +$4.41M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.7M | 3.6% |
94,984
-73,060
| -43% | -$8.29M |
|
|
6
Cencora
COR
$58.8B
| $10.1M | 3.13% |
100,545
+84,617
| +531% | +$7.79M |
|
7
Molina Healthcare
MOH
$12.6B
| $10.1M | 3.13% |
56,807
+20,834
| +58% | +$3.55M |
|
|
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.88M | 3.05% |
+90,000
| New | +$9.42M |
|
9
Merck
MRK
$298B
| $8.84M | 2.73% |
119,839
+22,288
| +23% | +$1.68M |
|
|
MRSN
10
DELISTED
Mersana Therapeutics
MRSN
| $8.7M | 2.69% |
14,871
+8,221
| +124% | +$2.81M |
|
|
RCM
11
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.51M | 2.63% |
+763,023
| New | +$7.85M |
|
12
Elevance Health
ELV
$92.7B
| $8.37M | 2.59% |
31,819
-26,050
| -45% | -$6.95M |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $8.03M | 2.48% |
2,299,982
+2,167,508
| +1,636% | +$6.25M |
|
|
SOLY
14
DELISTED
Soliton, Inc.
SOLY
| $7.97M | 2.47% |
+1,025,000
| New | +$10.1M |
|
15
HCA Healthcare
HCA
$80.7B
| $7.93M | 2.45% |
81,732
+3,800
| +5% | +$395K |
|
16
United Therapeutics
UTHR
$22.4B
| $7.89M | 2.44% |
65,210
-25,613
| -28% | -$2.88M |
|
17
Eli Lilly
LLY
$1.03T
| $7.54M | 2.33% |
+45,901
| New | +$7.05M |
|
18
Cardinal Health
CAH
$53.9B
| $6.97M | 2.15% |
+133,500
| New | +$6.88M |
|
|
BMY.RT
19
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $6.16M | 1.9% |
1,719,271
-527,629
| -23% | -$1.9M |
|
20
Orthofix Medical
OFIX
$443M
| $6.14M | 1.9% |
+191,891
| New | +$6.37M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.99M | 1.85% |
95,153
+10,000
| +12% | +$550K |
|
22
OraSure Technologies
OSUR
$293M
| $5.35M | 1.65% |
+460,000
| New | +$5.97M |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| $5.26M | 1.63% |
+124,194
| New | +$5.27M |
|
24
Curis
CRIS
$9.06M
| $5.2M | 1.61% |
+10,750
| New | +$3.96M |
|
25
Viking Therapeutics
VKTX
$4.41B
| $5.12M | 1.58% |
709,780
-42,461
| -6% | -$282K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA